A new study has shown that patients with Parkinson's disease experience changes not only in their sense of smell but also in their reaction to unpleasant odors—they do not hold their breath like healthy individuals do. These characteristics could serve as an additional diagnostic marker for the disease.
For the first time, the technology of epigenetic cell rejuvenation, previously tested successfully on animals, is moving into clinical trials in humans. The new drug ER-100 could pave the way for restoring retinal cell function and treating age-related eye diseases.
A new study has shown that untreated sleep apnea is linked to an increased risk of developing Parkinson's disease, while the use of CPAP therapy can significantly reduce this risk.